Rocket Lab (NASDAQ:RKLB) Shares Up 2% – Should You Buy?

Shares of Rocket Lab Corporation (NASDAQ:RKLB) shot up 2% during trading on Wednesday . The company traded as high as $68.67 and last traded at $65.52. 26,869,990 shares changed hands during trading, an increase of 20% from the average session volume of 22,374,689 shares. The stock had previously closed at $64.22.

Key Rocket Lab News

Here are the key news stories impacting Rocket Lab this week:

• Positive Sentiment: Germany and regulators approved Rocket Lab’s acquisition of Mynaric, strengthening in‑house laser communications capability and supply‑chain control. Rocket Lab Receives Regulatory Approval to Acquire Mynaric
• Positive Sentiment: Market reaction to Germany’s clearance pushed sentiment higher as analysts highlight expected supply benefits and synergy upside from Mynaric. Germany Greenlights Mynaric Acquisition
• Positive Sentiment: Rocket Lab landed a record ~$190M hypersonic HASTE contract with the U.S. Department of War (20 test flights), materially boosting multi‑year contracted backlog and defense revenue visibility. Does Rocket Lab’s Record Hypersonic Test Deal Redefine the Bull Case for RKLB?
• Positive Sentiment: Space sector momentum (reports SpaceX confidentially filed for an IPO) lifted aerospace peers including RKLB as investors rotate into the group. Planet Labs and Rocket Lab Stocks Surge after SpaceX IPO Filing
• Positive Sentiment: Management signaled discipline—CEO pay was cut and redirected to R&D—helping perceptions of capital allocation focus. Rocket Lab CEO Takes Pay Cut
• Neutral Sentiment: RKLB carries a sizable ~$1.85B backlog that supports 2026 revenue growth, but Zacks warns execution timing (Neutron delays), margin pressure and supplier constraints remain key risks. Backlog Provides Path to 2026 Revenue Growth
• Neutral Sentiment: Near‑term sentiment is also being driven by NASA’s Artemis II activity, which lifts space names but is more of a macro sentiment trade than a direct catalyst for RKLB fundamentals. NASA’s Artemis II Is About to Launch
• Negative Sentiment: The company filed a large new share sale program; while management says proceeds could fund growth, investors view it as potential dilution that can pressure the stock if shares are issued. Prediction: Rocket Lab Could Soar if This $1 Billion Bet Pays Off
• Negative Sentiment: Wells Fargo started coverage with an “equal weight” rating and $60 target, signaling near‑term valuation risk versus the current price. Wells Fargo Equal Weight $60 PT

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on the stock. KeyCorp lowered shares of Rocket Lab from an “overweight” rating to a “sector weight” rating in a research report on Thursday, January 15th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Rocket Lab in a research note on Thursday, January 22nd. Wells Fargo & Company started coverage on Rocket Lab in a report on Wednesday. They issued an “equal weight” rating and a $60.00 price target on the stock. Wall Street Zen raised Rocket Lab from a “sell” rating to a “hold” rating in a research note on Sunday, February 8th. Finally, TD Cowen restated a “buy” rating on shares of Rocket Lab in a report on Thursday, January 22nd. Two equities research analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, Rocket Lab currently has an average rating of “Moderate Buy” and an average price target of $79.42.

Rocket Lab Stock Up 2.0%

The company’s 50 day moving average is $72.64 and its 200 day moving average is $64.81. The company has a market cap of $37.18 billion, a PE ratio of -177.08 and a beta of 2.20. The company has a current ratio of 4.08, a quick ratio of 3.61 and a debt-to-equity ratio of 0.10.

Insider Buying and Selling at Rocket Lab

In related news, SVP Arjun Kampani sold 28,761 shares of the stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $69.59, for a total value of $2,001,477.99. Following the transaction, the senior vice president owned 421,699 shares of the company’s stock, valued at $29,346,033.41. This represents a 6.38% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Peter Beck sold 18,857 shares of the firm’s stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $69.59, for a total value of $1,312,258.63. Following the transaction, the chief executive officer owned 884,085 shares in the company, valued at $61,523,475.15. The trade was a 2.09% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 1,807,614 shares of company stock valued at $136,326,621. 11.90% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Rocket Lab

A number of hedge funds and other institutional investors have recently made changes to their positions in RKLB. AQR Capital Management LLC raised its holdings in shares of Rocket Lab by 114.0% in the first quarter. AQR Capital Management LLC now owns 174,308 shares of the rocket manufacturer’s stock valued at $3,117,000 after acquiring an additional 92,849 shares in the last quarter. NewEdge Advisors LLC lifted its stake in Rocket Lab by 1,812.1% in the first quarter. NewEdge Advisors LLC now owns 36,807 shares of the rocket manufacturer’s stock worth $658,000 after acquiring an additional 34,882 shares during the period. Jones Financial Companies Lllp grew its holdings in Rocket Lab by 53.8% during the 1st quarter. Jones Financial Companies Lllp now owns 15,745 shares of the rocket manufacturer’s stock worth $282,000 after acquiring an additional 5,507 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in Rocket Lab by 13.3% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 773,548 shares of the rocket manufacturer’s stock valued at $13,831,000 after purchasing an additional 90,758 shares during the period. Finally, Focus Partners Wealth increased its position in Rocket Lab by 1.0% during the 1st quarter. Focus Partners Wealth now owns 67,584 shares of the rocket manufacturer’s stock valued at $1,206,000 after purchasing an additional 681 shares during the period. Institutional investors own 71.78% of the company’s stock.

Rocket Lab Company Profile

Rocket Lab is an aerospace company that provides launch services, spacecraft, and space systems for commercial and government customers. The company’s primary launch vehicle is Electron, a small-lift orbital rocket designed to deploy small satellites and rideshare payloads to low Earth orbit. Rocket Lab also develops and manufactures the Rutherford engine, noted for its electric-pump-fed design and additive-manufactured components, which powers Electron and supports the company’s propulsion capabilities.